Not available
Quote | Aeterna Zentaris Inc. (NASDAQ:AEZS)
Last: | $1.96 |
---|---|
Change Percent: | 0.51% |
Open: | $1.96 |
Close: | $1.96 |
High: | $1.96 |
Low: | $1.9501 |
Volume: | 11,583 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Aeterna Zentaris Inc. (NASDAQ:AEZS)
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 - All-stock merger of equals transaction with Ceapro, Inc. expected to close i...
Message Board Posts | Aeterna Zentaris Inc. (NASDAQ:AEZS)
Subject | By | Source | When |
---|---|---|---|
were they trying to eliminate COVID -9.or what | ernie44 | investorshub | 04/09/2023 4:25:56 PM |
exactly,i have no idea what we were thinking,live | livendi | investorshub | 04/09/2023 3:17:43 AM |
Nearly all management had been in this company | Patrickwan1 | investorshub | 04/08/2023 9:10:31 PM |
This company has been listed for more than | Patrickwan1 | investorshub | 04/08/2023 8:07:06 PM |
me too bro,God bless and good luck | livendi | investorshub | 04/04/2023 7:13:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Aeterna Zentaris Inc. Company Name:
AEZS Stock Symbol:
NASDAQ Market:
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro ...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 - All-stock merger of equals transaction with Ceapro, Inc. expected to close i...